History-adjusted marginal structural analysis of the association between hemoglobin variability and mortality among chronic hemodialysis patients

被引:66
作者
Brunelli, Steven M. [1 ,2 ]
Joffe, Marshall M. [1 ,3 ]
Israni, Rubeen K. [1 ,2 ]
Yang, Wei [1 ]
Fishbane, Steven [4 ]
Berns, Jeffrey S. [2 ]
Feldman, Harold I. [1 ,3 ]
机构
[1] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Renal Electrolyte & Hypertens Div, Dept Med, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA
[4] Winthrop Univ Hosp, Mineola, NY 11501 USA
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2008年 / 3卷 / 03期
关键词
D O I
10.2215/CJN.04281007
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives: Hemoglobin variability is common among dialysis patients, and has been associated with increased mortality. The causal nature of this association has been difficult to ascertain because of potential time-dependent confounding, for which traditional statistical methods do not control. Design, settings, participants, & measurements: A retrospective cohort of 34,963 Fresenius Medical care dialysis patients from 1996 was assembled. Hemoglobin variability, absolute hemoglobin level, and temporal hemoglobin trend were measured over rolling 6-mo exposure windows. Their association with mortality was estimated using history-adjusted marginal structural analysis that adjusts for time-dependent confounding by applying weights to observations inversely related to the predictability of observed levels of hemoglobin. Results: In the primary analysis, each g/dl increase in hemoglobin variability was associated with an adjusted hazard ratio (HR) [95% confidence interval (CI)] for all-cause mortality of 1.93 (1.20 to 3.10). Neither higher absolute hemoglobin level nor increasing hemoglobin trend were significantly associated with mortality; adjusted HR (95% CI) 0.85 (0.64 to 1.11) and 0.60 (0.25 to 1.45), respectively. Conclusions: Marginal structural analysis demonstrates that hemoglobin variability is associated with increased mortality among chronic hemodialysis patients, and that this effect is more pronounced than appreciated using standard statistical techniques that do not take time-dependent confounding into account.
引用
收藏
页码:777 / 782
页数:6
相关论文
共 29 条
[1]   Hemoglobin variability in epoetin-treated hemodialysis patients [J].
Berns, JS ;
Elzein, H ;
Lynn, RI ;
Fishbane, S ;
Meisels, IS ;
DeOreo, PB .
KIDNEY INTERNATIONAL, 2003, 64 (04) :1514-1521
[2]   The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin [J].
Besarab, A ;
Bolton, WK ;
Browne, JK ;
Egrie, JC ;
Nissenson, AR ;
Okamoto, DM ;
Schwab, SJ ;
Goodkin, DA .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (09) :584-590
[3]   Use of a marginal structural model to determine the effect of aspirin on cardiovascular mortality in the physicians' health study [J].
Cook, NR ;
Cole, SR ;
Hennekens, CH .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 155 (11) :1045-1053
[4]   Hemoglobin level variability: Associations with comorbidity, intercurrent events, and hospitalizations [J].
Ebben, James P. ;
Gilbertson, David T. ;
Foley, Robert N. ;
Collins, Allan J. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 1 (06) :1205-1210
[5]  
Elliott MR., 2000, J OFF STAT, V16, P191
[6]   Administration of parenteral iron and mortality among hemodialysis patients [J].
Feldman, HI ;
Joffe, M ;
Robinson, B ;
Knauss, J ;
Cizman, B ;
Guo, WS ;
Franklin-Becker, E ;
Faich, G .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (06) :1623-1632
[7]   Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin [J].
Fishbane, S ;
Berns, JS .
KIDNEY INTERNATIONAL, 2005, 68 (03) :1337-1343
[8]  
Georgieva Z, 1997, CLIN HEMORHEOL MICRO, V17, P21
[9]  
GILBERTSON DT, 2006, EFFECT HEMOGLOBIN VA
[10]  
GILBERTSON DT, 2006, ERD EDTA C GLASG UK